SPONSOR
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Non-small Cell Lung CancerMetastatic Non-Small Cell Lung CancerNSCLCKRAS G12CMetastatic Lung CancerAdvanced Lung Carcinoma
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
How many clinical trials has TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), of which 1 are actively recruiting participants. These trials cover conditions including Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) research focus on?
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) clinical trials span Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, KRAS G12C, Metastatic Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) clinical trial?
To participate in a TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) trials with current recruitment status updated daily.
Clinical Trials by TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology